Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Quantification of lymph node transit times reveals differences in antigen surveillance strategies of naive CD4+ and CD8+ T cells.

Tytuł:
Quantification of lymph node transit times reveals differences in antigen surveillance strategies of naive CD4+ and CD8+ T cells.
Autorzy:
Mandl JN; Lymphocyte Biology Section, Laboratory of Systems Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Liou R
Klauschen F
Vrisekoop N
Monteiro JP
Yates AJ
Huang AY
Germain RN
Źródło:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2012 Oct 30; Vol. 109 (44), pp. 18036-41. Date of Electronic Publication: 2012 Oct 15.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
Język:
English
Imprint Name(s):
Original Publication: Washington, DC : National Academy of Sciences
MeSH Terms:
Antigens/*immunology
CD4-Positive T-Lymphocytes/*cytology
CD8-Positive T-Lymphocytes/*cytology
Lymph Nodes/*cytology
CD4-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/immunology ; Humans ; Lymph Nodes/immunology
References:
Immunity. 2007 Aug;27(2):203-13. (PMID: 17707129)
Proc Natl Acad Sci U S A. 2004 Jan 27;101(4):998-1003. (PMID: 14722354)
Immunity. 2008 Jan;28(1):122-33. (PMID: 18164221)
Nature. 2006 Apr 13;440(7086):890-5. (PMID: 16612374)
Science. 2002 Jun 7;296(5574):1869-73. (PMID: 12016203)
Curr Opin Immunol. 2007 Jun;19(3):249-58. (PMID: 17433876)
Science. 1999 Dec 10;286(5447):2098-102. (PMID: 10617422)
Science. 2002 Jun 7;296(5574):1873-6. (PMID: 12052961)
Proc R Soc Lond B Biol Sci. 1964 Jan 14;159:257-82. (PMID: 14114163)
Eur J Immunol. 2005 Sep;35(9):2563-72. (PMID: 16078277)
Nat Rev Immunol. 2003 Nov;3(11):867-78. (PMID: 14668803)
Nat Immunol. 2003 Jun;4(6):579-85. (PMID: 12730692)
J Immunol. 2007 Mar 1;178(5):2973-8. (PMID: 17312142)
J Exp Med. 1998 Dec 21;188(12):2301-11. (PMID: 9858516)
Nature. 2011 Nov 13;479(7374):542-6. (PMID: 22080953)
J Exp Med. 2007 Mar 19;204(3):489-95. (PMID: 17325198)
Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20447-52. (PMID: 21059923)
Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8744-9. (PMID: 11447257)
Nat Rev Immunol. 2006 Jul;6(7):497-507. (PMID: 16799470)
Immunol Rev. 2008 Feb;221:44-63. (PMID: 18275474)
Immunity. 2011 Dec 23;35(6):945-57. (PMID: 22195748)
Nature. 2004 Jan 8;427(6970):154-9. (PMID: 14712275)
Nat Immunol. 2009 Jan;10(1):58-65. (PMID: 19060900)
J Clin Invest. 2011 Mar;121(3):998-1008. (PMID: 21393864)
Blood. 2006 Jul 1;108(1):270-7. (PMID: 16527889)
Nat Immunol. 2000 Oct;1(4):329-35. (PMID: 11017105)
J Exp Med. 2009 Sep 28;206(10):2253-69. (PMID: 19752186)
Nature. 2002 Nov 28;420(6914):429-34. (PMID: 12459785)
Immunity. 2006 Dec;25(6):989-1001. (PMID: 17112751)
Nat Immunol. 2007 Nov;8(11):1255-65. (PMID: 17893676)
Nat Immunol. 2007 Dec;8(12):1295-301. (PMID: 18026082)
Nat Immunol. 2007 May;8(5):532-9. (PMID: 17401367)
Nature. 2006 Mar 23;440(7083):540-4. (PMID: 16525420)
Blood. 2012 Aug 16;120(7):1432-8. (PMID: 22773385)
Science. 2006 Apr 7;312(5770):114-6. (PMID: 16513943)
Immunity. 2001 Jul;15(1):71-82. (PMID: 11485739)
Eur J Immunol. 1988 Dec;18(12):2093-6. (PMID: 2905997)
J Exp Med. 2007 Apr 16;204(4):771-80. (PMID: 17389236)
Immunity. 2008 Jun;28(6):859-69. (PMID: 18499487)
J Exp Med. 2002 Jul 1;196(1):65-75. (PMID: 12093871)
Immunology. 1983 May;49(1):83-94. (PMID: 6840811)
Grant Information:
R01 CA154656-01 United States CA NCI NIH HHS; R01 CA154656 United States CA NCI NIH HHS; R21 AI092299 United States AI NIAID NIH HHS; United States ImNIH Intramural NIH HHS; R21 AI092299-01 United States AI NIAID NIH HHS; R01 AI093870 United States AI NIAID NIH HHS; R01AI093870-01 United States AI NIAID NIH HHS
Substance Nomenclature:
0 (Antigens)
Entry Date(s):
Date Created: 20121017 Date Completed: 20130108 Latest Revision: 20211021
Update Code:
20240104
PubMed Central ID:
PMC3497782
DOI:
10.1073/pnas.1211717109
PMID:
23071319
Czasopismo naukowe
Naïve T cells continually recirculate between blood and secondary lymphoid organs, scanning dendritic cells (DC) for foreign antigen. Despite its importance for understanding how adaptive immune responses are efficiently initiated from rare precursors, a detailed quantitative analysis of this fundamental process has not been reported. Here we measure lymph node (LN) entry, transit, and exit rates for naïve CD4(+) and CD8(+) T cells, then use intravital imaging and mathematical modeling to relate cell-cell interaction dynamics to population behavior. Our studies reveal marked differences between CD4(+) vs. CD8(+) T cells. CD4(+) T cells recirculate more rapidly, homing to LNs more efficiently, traversing LNs twice as quickly, and spending ∼1/3 of their transit time interacting with MHCII on DC. In contrast, adoptively transferred CD8(+) T cells enter and leave the LN more slowly, with a transit time unaffected by the absence of MHCI molecules on host cells. Together, these data reveal an unexpectedly asymmetric role for MHC interactions in controlling CD4(+) vs. CD8(+) T lymphocyte recirculation, as well as distinct contributions of T cell receptor (TCR)-independent factors to the LN transit time, exposing the divergent surveillance strategies used by the two lymphocyte populations in scanning for foreign antigen.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies